D. Medical Rises Most in Two Weeks on Potential Acquisition
By Shoshanna Solomon -
2012-06-19T13:18:54Z
D. Medical Industries Ltd. (DMED) rose the most in almost two weeks after the maker of drug delivery devices said it is negotiating a potential acquisition of a diabetes devices company.
The shares surged 7.9 percent, the most since June 7, to 1.605 shekels, at 4:05 p.m. in Tel Aviv, lifting the company’s market value to 17.4 million shekels ($4.5 million).
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net
To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net
Sponsored Link

Rate this Page
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.